Robert DeSantis - 14 Jun 2023 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Jun 2023, 17:04:00 UTC
Prior SEC filing
12 May 2023
Next SEC filing
26 Jul 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Donna Spinola For: DeSantis, Robert

Key filing fact

Robert DeSantis filed Form 4 for INTUITIVE SURGICAL INC (ISRG) on 15 Jun 2023.

Key facts

  • This page summarizes Robert DeSantis's Form 4 filing for INTUITIVE SURGICAL INC (ISRG).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Jun 2023, 17:04.

Change

  • Previous filing in this sequence was filed on 12 May 2023.
  • Current net transaction value: -$84,699.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ISRG transaction

Common Stock

Options Exercise

Transaction value
$709,276
Shares
+2,443
Change %
+34%
Price
$290.33
Shares after
9,702
Date
14 Jun 2023
Ownership
Direct
Footnotes
F1
ISRG transaction

Common Stock

Sale

Transaction value
$793,975
Shares
-2,443
Change %
-25%
Price
$325.00
Shares after
7,259
Date
14 Jun 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ISRG transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-2,443
Change %
-27%
Price
$0.000000
Shares after
6,580
Date
14 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,443
Exercise price
$290.33
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

Footnote F2

Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .